16th April 2022 | Pharma Updates

Covid cases on the rise in Maharashtra, Delhi-NCR, and Haryana

The national capital has seen an increase in Covid-19 cases in the last two days, prompting the Delhi government to say it is closely monitoring the situation and has increased the availability of medicines, hospital beds, and oxygen capacity.

According to DCGI, India on track to become a global drug hub

Dr. VG Somani, Drug Controller General of India (DCGI), claimed that India is on path to becoming a “global hub for medicines, ” claiming that there has been a fourfold increase in applications for investigational new drugs in the country.

Pfizer aiming for a COVID booster for healthy children aged 5 to 11

In a small study, 140 children who had already received two vaccinations were given a booster six months later, and researchers discovered that the additional shot generally increased their immune response.

People suffering from psychosis or anxiety at a high risk of Covid relapse

People who have a history of certain psychiatric conditions, such as psychosis or anxiety, are more likely to develop COVID-19 and risky behaviours associated with some disorders.

Moderna's COVID shotfor children aged 6 to 11 years old approved in Britain

Britain’s medicines regulator approved the use of Moderna’s COVID-19 vaccine in children aged six to eleven years old, as the country prepares to combat coronavirus infections in the face of the spread of new virus variants.

So far, no change in the severity or transmissibility of Omicron BA.4, BA.5: WHO

While there have been a few cases of new Omicron sub-variants BA.4 and BA.5, the World Health Organization reports that there has been no change in severity or transmissibility.

USFDA approved the first COVID-19 diagnostic test using breath samples

The test detects chemicals associated with the virus that causes the disease in a breath sample, and if it is positive, a molecular test should be performed.